Primary |
Clostridium Difficile Colitis |
31.8% |
Clostridial Infection |
26.5% |
Product Used For Unknown Indication |
7.5% |
Hypertension |
6.5% |
Diarrhoea |
3.3% |
Depression |
2.9% |
Crohn's Disease |
2.8% |
Diabetes Mellitus |
2.6% |
Anxiety |
2.4% |
Supplementation Therapy |
2.0% |
Pain |
1.8% |
Clostridium Test Positive |
1.6% |
Prophylaxis |
1.4% |
Vitamin Supplementation |
1.4% |
Hypothyroidism |
1.2% |
Pain Management |
1.2% |
Atrial Fibrillation |
1.0% |
Bipolar Disorder |
0.8% |
Blood Cholesterol Increased |
0.8% |
Gastrooesophageal Reflux Disease |
0.8% |
|
Disease Recurrence |
27.1% |
Off Label Use |
10.6% |
Diarrhoea |
9.4% |
Drug Ineffective |
8.8% |
Pyrexia |
4.7% |
Weight Decreased |
4.7% |
Nausea |
4.1% |
Treatment Failure |
4.1% |
Vomiting |
4.1% |
Abdominal Pain |
3.5% |
Death |
2.4% |
Infection |
2.4% |
Mucous Stools |
2.4% |
Faeces Discoloured |
1.8% |
Gastrointestinal Sounds Abnormal |
1.8% |
No Therapeutic Response |
1.8% |
Pain |
1.8% |
Rash |
1.8% |
Tinnitus |
1.8% |
Cardiac Disorder |
1.2% |
|
Secondary |
Clostridial Infection |
22.5% |
Clostridium Difficile Colitis |
21.5% |
Hypertension |
9.5% |
Diarrhoea |
6.0% |
Clostridium Difficile Infection |
5.5% |
Diabetes Mellitus |
5.0% |
Anxiety |
3.5% |
Product Used For Unknown Indication |
3.5% |
Prophylaxis |
3.5% |
Pain Management |
3.0% |
Antibiotic Prophylaxis |
2.5% |
Tooth Infection |
2.5% |
Bipolar Disorder |
2.0% |
Clostridium Test Positive |
2.0% |
Depression |
2.0% |
Arthralgia |
1.5% |
Asthma |
1.0% |
Cardiac Disorder |
1.0% |
Hepatic Cirrhosis |
1.0% |
Hormone Therapy |
1.0% |
|
Disease Recurrence |
22.6% |
Weight Decreased |
14.5% |
Infection |
8.1% |
Diarrhoea |
6.5% |
Treatment Failure |
6.5% |
No Therapeutic Response |
4.8% |
Off Label Use |
4.8% |
Clostridium Difficile Colitis |
3.2% |
Multi-organ Failure |
3.2% |
Nausea |
3.2% |
Pyrexia |
3.2% |
Respiratory Failure |
3.2% |
Tinnitus |
3.2% |
Vomiting |
3.2% |
Abdominal Pain |
1.6% |
Colitis Ischaemic |
1.6% |
Constipation |
1.6% |
Death |
1.6% |
Drug Dispensing Error |
1.6% |
Drug Dose Omission |
1.6% |
|
Concomitant |
Product Used For Unknown Indication |
47.8% |
Crohn's Disease |
13.0% |
Clostridium Difficile Colitis |
8.7% |
Colitis Ulcerative |
8.7% |
Blood Cholesterol Increased |
4.3% |
Blood Testosterone Decreased |
4.3% |
Hypertension |
4.3% |
Mineral Supplementation |
4.3% |
Pain |
4.3% |
|
Colitis Ulcerative |
28.6% |
Clostridial Infection |
14.3% |
Clostridium Difficile Colitis |
14.3% |
Haematuria |
14.3% |
Local Swelling |
14.3% |
Vomiting |
14.3% |
|
Interacting |
Dyspepsia |
16.7% |
Anxiety |
8.3% |
Back Pain |
8.3% |
Clostridium Difficile Colitis |
8.3% |
Convulsion |
8.3% |
Crohn's Disease |
8.3% |
Diarrhoea |
8.3% |
Muscle Relaxant Therapy |
8.3% |
Product Used For Unknown Indication |
8.3% |
Sleep Disorder |
8.3% |
Ulcer |
8.3% |
|
|